Lifecore Biomedical, Inc. (LFCR) vs Sofgen Pharma S.A (PROCF)
Lifecore Biomedical, Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $162.4M against $114.0M — 1.4× the size. Sofgen Pharma S.A grew revenue faster over the last twelve months: 5.10% against −10.0%. Sofgen Pharma S.A has the higher net margin (9.52% vs −37.5%) and the higher return on invested capital (15.2% vs −2.80%). Across the 16 metrics below, Sofgen Pharma S.A leads on 13 and Lifecore Biomedical, Inc. on 3.
Valuation
Profitability
| Metric | LFCR | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 26.86% | 56.16% | 53.94% |
| Operating margin | (6.89%) | 17.01% | 0.00% |
| Net margin | (37.54%) | 9.52% | 0.00% |
| Free cash flow margin | (4.24%) | 17.66% | 0.00% |
| Return on equity | 201.15% | (213.06%) | (0.40%) |
| Return on assets | (19.32%) | 8.82% | (3.32%) |
| Return on invested capital | (2.80%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack